During the past decade, Klinische Forschung Karlsruhe GmbH conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinische Forschung Karlsruhe GmbH" #1 sponsor was "Idorsia Pharmaceuticals Ltd." with 2 trials, followed by "Aboca Spa Societa' Agricola" with 1 trials sponsored, "Allergan" with 1 trials sponsored, "Asarina Pharma" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinische Forschung Karlsruhe GmbH" #1 collaborator was "Ergomed" with 1 trials as a collaborator, "IQVIA RDS" with 1 trials as a collaborator and "IQVIA Solutions" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Klinische Forschung Karlsruhe GmbH" are "Insomnia Disorder" (2 trials), "Diabetes Mellitus" (1 trials), "Gastroparesis" (1 trials), "Irritable Bowel Syndrome" (1 trials) and "NASH - Nonalcoholic Steatohepatitis" (1 trials). Many other conditions were trialed in "Klinische Forschung Karlsruhe GmbH" in a lesser frequency.

Most popular intervention types in "Klinische Forschung Karlsruhe GmbH" are "Drug" (6 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Daridorexant 25 mg" (2 trials), "Daridorexant 50 mg" (2 trials), "BAY2395840" (1 trials) and "Colilen IBS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinische Forschung Karlsruhe GmbH" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Klinische Forschung Karlsruhe GmbH". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Klinische Forschung Karlsruhe GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinische Forschung Karlsruhe GmbH, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".